
Time left to apply
Connect to US
Are you ready to amplify your impact and expand into the U.S.? The Boston-Cambridge ecosystem—home to Bayer Co.Lab Cambridge—leads the world in biotech innovation, offering unparalleled opportunities to scale and thrive.
Bayer Co.Lab Connect is your gateway to this dynamic market. We provide non-U.S. startups with the tools, networks, and resources needed to establish a foothold in the U.S. from Bayer Co.Lab Cambridge, in the most innovative square mile on the planet, and achieve sustainable growth with Bayer’s expertise and support.
Benefits
Qualifications
Stage
Startups from concept to Series A stages. In particular, non-U.S. companies looking for support to build a presence in Boston-Cambridge, USA
Focus Areas
Precision medicine, precision cardiovascular, precision nephrology, CNS and aging diseases, immunology, tissue-targeting technologies, precision oncology, cardiology or renal disease, and cell and gene therapy solutions.
Country of Origin
Japan and Switzerland
Prizes
Inclusion in the Bayer Co.Lab portfolio (no strings attached)
A travel grant to partially cover expenses for a trip to Boston to participate in a Bayer event during BIO International 2025
Complimentary access to a workspace for business development at Bayer Co.Lab Cambridge (USA)
Exposure to Bayer’s R&D and BD&L teams and mentoring sessions
Warm introductions to several Boston-based investors and vetted service providers
Take the Next Step
One startup from Switzerland and up to one from Japan will be selected to join Bayer Co.Lab Connect. We don’t believe in limitations – and neither should you! This is your opportunity to expand in the U.S. market, gain credibility, and connect with leaders in the biotech industry.